nodes	percent_of_prediction	percent_of_DWPC	metapath
Triamcinolone—Thromboembolism—Sorafenib—liver cancer	0.0237	0.0367	CcSEcCtD
Triamcinolone—Skin scaly—Epirubicin—liver cancer	0.0206	0.0318	CcSEcCtD
Triamcinolone—Skin scaly—Doxorubicin—liver cancer	0.0191	0.0295	CcSEcCtD
Triamcinolone—Embolism venous—Sorafenib—liver cancer	0.015	0.0231	CcSEcCtD
Triamcinolone—Folliculitis—Sorafenib—liver cancer	0.012	0.0185	CcSEcCtD
Triamcinolone—Embolism—Sorafenib—liver cancer	0.0118	0.0182	CcSEcCtD
Triamcinolone—Oropharyngeal discomfort—Sorafenib—liver cancer	0.0104	0.016	CcSEcCtD
Triamcinolone—Secondary infection—Epirubicin—liver cancer	0.00949	0.0147	CcSEcCtD
Triamcinolone—Secondary infection—Doxorubicin—liver cancer	0.00878	0.0136	CcSEcCtD
Triamcinolone—Thromboembolism—Epirubicin—liver cancer	0.00877	0.0135	CcSEcCtD
Triamcinolone—Thromboembolism—Doxorubicin—liver cancer	0.00812	0.0125	CcSEcCtD
Triamcinolone—Cardiomegaly—Epirubicin—liver cancer	0.00765	0.0118	CcSEcCtD
Triamcinolone—BCHE—diaphragm—liver cancer	0.00744	0.615	CbGeAlD
Triamcinolone—Skin exfoliation—Sorafenib—liver cancer	0.00721	0.0111	CcSEcCtD
Triamcinolone—Neuropathy—Sorafenib—liver cancer	0.00709	0.0109	CcSEcCtD
Triamcinolone—Cardiomegaly—Doxorubicin—liver cancer	0.00708	0.0109	CcSEcCtD
Triamcinolone—Leukoderma—Epirubicin—liver cancer	0.00656	0.0101	CcSEcCtD
Triamcinolone—Leukoderma—Doxorubicin—liver cancer	0.00607	0.00938	CcSEcCtD
Triamcinolone—Cardiac failure congestive—Sorafenib—liver cancer	0.00604	0.00933	CcSEcCtD
Triamcinolone—Embolism venous—Epirubicin—liver cancer	0.00553	0.00854	CcSEcCtD
Triamcinolone—Hypernatraemia—Epirubicin—liver cancer	0.00531	0.00819	CcSEcCtD
Triamcinolone—Mood swings—Sorafenib—liver cancer	0.00519	0.00802	CcSEcCtD
Triamcinolone—Embolism venous—Doxorubicin—liver cancer	0.00512	0.0079	CcSEcCtD
Triamcinolone—Blindness—Epirubicin—liver cancer	0.00504	0.00778	CcSEcCtD
Triamcinolone—Hypernatraemia—Doxorubicin—liver cancer	0.00491	0.00758	CcSEcCtD
Triamcinolone—Skin hyperpigmentation—Epirubicin—liver cancer	0.00469	0.00724	CcSEcCtD
Triamcinolone—Blindness—Doxorubicin—liver cancer	0.00466	0.0072	CcSEcCtD
Triamcinolone—Pancreatitis—Sorafenib—liver cancer	0.00464	0.00717	CcSEcCtD
Triamcinolone—Optic neuritis—Epirubicin—liver cancer	0.00454	0.007	CcSEcCtD
Triamcinolone—Folliculitis—Epirubicin—liver cancer	0.00444	0.00685	CcSEcCtD
Triamcinolone—Embolism—Epirubicin—liver cancer	0.00435	0.00671	CcSEcCtD
Triamcinolone—Skin hyperpigmentation—Doxorubicin—liver cancer	0.00434	0.0067	CcSEcCtD
Triamcinolone—Optic neuritis—Doxorubicin—liver cancer	0.0042	0.00648	CcSEcCtD
Triamcinolone—Acute coronary syndrome—Sorafenib—liver cancer	0.00416	0.00643	CcSEcCtD
Triamcinolone—Myocardial infarction—Sorafenib—liver cancer	0.00414	0.00639	CcSEcCtD
Triamcinolone—Neuropathy peripheral—Sorafenib—liver cancer	0.00414	0.00639	CcSEcCtD
Triamcinolone—Folliculitis—Doxorubicin—liver cancer	0.00411	0.00634	CcSEcCtD
Triamcinolone—Embolism—Doxorubicin—liver cancer	0.00402	0.00621	CcSEcCtD
Triamcinolone—Epistaxis—Sorafenib—liver cancer	0.00398	0.00615	CcSEcCtD
Triamcinolone—Hepatomegaly—Epirubicin—liver cancer	0.00394	0.00609	CcSEcCtD
Triamcinolone—Blister—Epirubicin—liver cancer	0.00387	0.00598	CcSEcCtD
Triamcinolone—Haemoglobin—Sorafenib—liver cancer	0.00381	0.00588	CcSEcCtD
Triamcinolone—Haemorrhage—Sorafenib—liver cancer	0.00379	0.00585	CcSEcCtD
Triamcinolone—Dermatitis atopic—Epirubicin—liver cancer	0.00377	0.00582	CcSEcCtD
Triamcinolone—Neuritis—Epirubicin—liver cancer	0.00374	0.00577	CcSEcCtD
Triamcinolone—Hepatomegaly—Doxorubicin—liver cancer	0.00365	0.00563	CcSEcCtD
Triamcinolone—Blister—Doxorubicin—liver cancer	0.00358	0.00553	CcSEcCtD
Triamcinolone—Abscess—Epirubicin—liver cancer	0.00353	0.00544	CcSEcCtD
Triamcinolone—Dermatitis atopic—Doxorubicin—liver cancer	0.00349	0.00539	CcSEcCtD
Triamcinolone—Neuritis—Doxorubicin—liver cancer	0.00346	0.00534	CcSEcCtD
Triamcinolone—Stinging—Epirubicin—liver cancer	0.00344	0.00532	CcSEcCtD
Triamcinolone—Glycosuria—Epirubicin—liver cancer	0.00344	0.00532	CcSEcCtD
Triamcinolone—Petechiae—Epirubicin—liver cancer	0.00339	0.00524	CcSEcCtD
Triamcinolone—Arrhythmia—Sorafenib—liver cancer	0.00339	0.00523	CcSEcCtD
Triamcinolone—Erythema—Sorafenib—liver cancer	0.0033	0.0051	CcSEcCtD
Triamcinolone—Abscess—Doxorubicin—liver cancer	0.00326	0.00504	CcSEcCtD
Triamcinolone—Dysgeusia—Sorafenib—liver cancer	0.00323	0.00499	CcSEcCtD
Triamcinolone—Glycosuria—Doxorubicin—liver cancer	0.00319	0.00492	CcSEcCtD
Triamcinolone—Stinging—Doxorubicin—liver cancer	0.00319	0.00492	CcSEcCtD
Triamcinolone—Petechiae—Doxorubicin—liver cancer	0.00314	0.00485	CcSEcCtD
Triamcinolone—Arthropathy—Epirubicin—liver cancer	0.00307	0.00474	CcSEcCtD
Triamcinolone—Cough increased—Epirubicin—liver cancer	0.00305	0.00471	CcSEcCtD
Triamcinolone—Angioedema—Sorafenib—liver cancer	0.00302	0.00466	CcSEcCtD
Triamcinolone—Syncope—Sorafenib—liver cancer	0.00296	0.00457	CcSEcCtD
Triamcinolone—Ulcer—Epirubicin—liver cancer	0.00295	0.00455	CcSEcCtD
Triamcinolone—Loss of consciousness—Sorafenib—liver cancer	0.0029	0.00448	CcSEcCtD
Triamcinolone—Cough—Sorafenib—liver cancer	0.00288	0.00445	CcSEcCtD
Triamcinolone—Hypertension—Sorafenib—liver cancer	0.00285	0.0044	CcSEcCtD
Triamcinolone—Arthropathy—Doxorubicin—liver cancer	0.00284	0.00438	CcSEcCtD
Triamcinolone—Cough increased—Doxorubicin—liver cancer	0.00282	0.00435	CcSEcCtD
Triamcinolone—Myalgia—Sorafenib—liver cancer	0.00281	0.00434	CcSEcCtD
Triamcinolone—Hiccups—Epirubicin—liver cancer	0.00279	0.00431	CcSEcCtD
Triamcinolone—Dermatitis contact—Epirubicin—liver cancer	0.00276	0.00426	CcSEcCtD
Triamcinolone—Dry mouth—Sorafenib—liver cancer	0.00275	0.00424	CcSEcCtD
Triamcinolone—Ulcer—Doxorubicin—liver cancer	0.00273	0.00421	CcSEcCtD
Triamcinolone—Anaphylactic shock—Sorafenib—liver cancer	0.00269	0.00416	CcSEcCtD
Triamcinolone—Infection—Sorafenib—liver cancer	0.00268	0.00413	CcSEcCtD
Triamcinolone—Candida infection—Epirubicin—liver cancer	0.00266	0.00411	CcSEcCtD
Triamcinolone—Skin exfoliation—Epirubicin—liver cancer	0.00266	0.00411	CcSEcCtD
Triamcinolone—Shock—Sorafenib—liver cancer	0.00265	0.00409	CcSEcCtD
Triamcinolone—Fluid retention—Epirubicin—liver cancer	0.00265	0.00409	CcSEcCtD
Triamcinolone—Neuropathy—Epirubicin—liver cancer	0.00262	0.00404	CcSEcCtD
Triamcinolone—Hiccups—Doxorubicin—liver cancer	0.00258	0.00399	CcSEcCtD
Triamcinolone—Dermatitis contact—Doxorubicin—liver cancer	0.00255	0.00394	CcSEcCtD
Triamcinolone—Ecchymosis—Epirubicin—liver cancer	0.00252	0.0039	CcSEcCtD
Triamcinolone—Pulmonary oedema—Epirubicin—liver cancer	0.00248	0.00383	CcSEcCtD
Triamcinolone—Skin exfoliation—Doxorubicin—liver cancer	0.00246	0.00381	CcSEcCtD
Triamcinolone—Candida infection—Doxorubicin—liver cancer	0.00246	0.00381	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00245	0.00379	CcSEcCtD
Triamcinolone—Fluid retention—Doxorubicin—liver cancer	0.00245	0.00378	CcSEcCtD
Triamcinolone—Neuropathy—Doxorubicin—liver cancer	0.00242	0.00374	CcSEcCtD
Triamcinolone—Dyspnoea—Sorafenib—liver cancer	0.0024	0.00371	CcSEcCtD
Triamcinolone—Dyspepsia—Sorafenib—liver cancer	0.00237	0.00366	CcSEcCtD
Triamcinolone—Thrombophlebitis—Epirubicin—liver cancer	0.00234	0.00361	CcSEcCtD
Triamcinolone—Ecchymosis—Doxorubicin—liver cancer	0.00233	0.0036	CcSEcCtD
Triamcinolone—Diabetes mellitus—Epirubicin—liver cancer	0.00233	0.0036	CcSEcCtD
Triamcinolone—Fatigue—Sorafenib—liver cancer	0.00232	0.00359	CcSEcCtD
Triamcinolone—Pain—Sorafenib—liver cancer	0.0023	0.00356	CcSEcCtD
Triamcinolone—Pulmonary oedema—Doxorubicin—liver cancer	0.0023	0.00355	CcSEcCtD
Triamcinolone—Vascular purpura—Epirubicin—liver cancer	0.00226	0.0035	CcSEcCtD
Triamcinolone—Cardiac failure congestive—Epirubicin—liver cancer	0.00223	0.00345	CcSEcCtD
Triamcinolone—Thrombophlebitis—Doxorubicin—liver cancer	0.00216	0.00334	CcSEcCtD
Triamcinolone—Increased appetite—Epirubicin—liver cancer	0.00216	0.00333	CcSEcCtD
Triamcinolone—Diabetes mellitus—Doxorubicin—liver cancer	0.00215	0.00333	CcSEcCtD
Triamcinolone—Urticaria—Sorafenib—liver cancer	0.00214	0.0033	CcSEcCtD
Triamcinolone—Body temperature increased—Sorafenib—liver cancer	0.00213	0.00329	CcSEcCtD
Triamcinolone—Dermatitis bullous—Epirubicin—liver cancer	0.00212	0.00327	CcSEcCtD
Triamcinolone—Purpura—Epirubicin—liver cancer	0.0021	0.00324	CcSEcCtD
Triamcinolone—Vascular purpura—Doxorubicin—liver cancer	0.00209	0.00323	CcSEcCtD
Triamcinolone—Anaphylactoid reaction—Epirubicin—liver cancer	0.00209	0.00323	CcSEcCtD
Triamcinolone—Cardiac failure congestive—Doxorubicin—liver cancer	0.00207	0.00319	CcSEcCtD
Triamcinolone—Osteoarthritis—Epirubicin—liver cancer	0.00203	0.00313	CcSEcCtD
Triamcinolone—Increased appetite—Doxorubicin—liver cancer	0.00199	0.00308	CcSEcCtD
Triamcinolone—Affect lability—Epirubicin—liver cancer	0.00199	0.00308	CcSEcCtD
Triamcinolone—Hypersensitivity—Sorafenib—liver cancer	0.00198	0.00306	CcSEcCtD
Triamcinolone—Dermatitis bullous—Doxorubicin—liver cancer	0.00196	0.00303	CcSEcCtD
Triamcinolone—Purpura—Doxorubicin—liver cancer	0.00194	0.003	CcSEcCtD
Triamcinolone—Anaphylactoid reaction—Doxorubicin—liver cancer	0.00194	0.00299	CcSEcCtD
Triamcinolone—Asthenia—Sorafenib—liver cancer	0.00193	0.00298	CcSEcCtD
Triamcinolone—Cardiac arrest—Epirubicin—liver cancer	0.00193	0.00297	CcSEcCtD
Triamcinolone—Mood swings—Epirubicin—liver cancer	0.00192	0.00296	CcSEcCtD
Triamcinolone—Pruritus—Sorafenib—liver cancer	0.00191	0.00294	CcSEcCtD
Triamcinolone—Osteoarthritis—Doxorubicin—liver cancer	0.00187	0.00289	CcSEcCtD
Triamcinolone—Affect lability—Doxorubicin—liver cancer	0.00184	0.00285	CcSEcCtD
Triamcinolone—Muscular weakness—Epirubicin—liver cancer	0.00179	0.00276	CcSEcCtD
Triamcinolone—Cardiac arrest—Doxorubicin—liver cancer	0.00178	0.00275	CcSEcCtD
Triamcinolone—Dizziness—Sorafenib—liver cancer	0.00178	0.00275	CcSEcCtD
Triamcinolone—Mood swings—Doxorubicin—liver cancer	0.00178	0.00274	CcSEcCtD
Triamcinolone—Abdominal distension—Epirubicin—liver cancer	0.00176	0.00272	CcSEcCtD
Triamcinolone—Asthma—Epirubicin—liver cancer	0.00175	0.0027	CcSEcCtD
Triamcinolone—Influenza—Epirubicin—liver cancer	0.00175	0.0027	CcSEcCtD
Triamcinolone—Pancreatitis—Epirubicin—liver cancer	0.00172	0.00265	CcSEcCtD
Triamcinolone—Vomiting—Sorafenib—liver cancer	0.00171	0.00264	CcSEcCtD
Triamcinolone—Rash—Sorafenib—liver cancer	0.0017	0.00262	CcSEcCtD
Triamcinolone—Dermatitis—Sorafenib—liver cancer	0.0017	0.00262	CcSEcCtD
Triamcinolone—Headache—Sorafenib—liver cancer	0.00169	0.00261	CcSEcCtD
Triamcinolone—Bronchitis—Epirubicin—liver cancer	0.00168	0.0026	CcSEcCtD
Triamcinolone—Muscular weakness—Doxorubicin—liver cancer	0.00165	0.00255	CcSEcCtD
Triamcinolone—Abdominal distension—Doxorubicin—liver cancer	0.00163	0.00252	CcSEcCtD
Triamcinolone—Upper respiratory tract infection—Epirubicin—liver cancer	0.00163	0.00251	CcSEcCtD
Triamcinolone—Influenza—Doxorubicin—liver cancer	0.00162	0.0025	CcSEcCtD
Triamcinolone—Asthma—Doxorubicin—liver cancer	0.00162	0.0025	CcSEcCtD
Triamcinolone—Nausea—Sorafenib—liver cancer	0.0016	0.00247	CcSEcCtD
Triamcinolone—Weight increased—Epirubicin—liver cancer	0.00159	0.00246	CcSEcCtD
Triamcinolone—Pancreatitis—Doxorubicin—liver cancer	0.00159	0.00245	CcSEcCtD
Triamcinolone—Bronchitis—Doxorubicin—liver cancer	0.00156	0.00241	CcSEcCtD
Triamcinolone—Neuropathy peripheral—Epirubicin—liver cancer	0.00153	0.00236	CcSEcCtD
Triamcinolone—Conjunctivitis—Epirubicin—liver cancer	0.00152	0.00234	CcSEcCtD
Triamcinolone—Upper respiratory tract infection—Doxorubicin—liver cancer	0.00151	0.00232	CcSEcCtD
Triamcinolone—Weight increased—Doxorubicin—liver cancer	0.00147	0.00228	CcSEcCtD
Triamcinolone—Epistaxis—Epirubicin—liver cancer	0.00147	0.00227	CcSEcCtD
Triamcinolone—Bradycardia—Epirubicin—liver cancer	0.00143	0.0022	CcSEcCtD
Triamcinolone—Neuropathy peripheral—Doxorubicin—liver cancer	0.00142	0.00219	CcSEcCtD
Triamcinolone—Haemoglobin—Epirubicin—liver cancer	0.00141	0.00217	CcSEcCtD
Triamcinolone—Rhinitis—Epirubicin—liver cancer	0.0014	0.00217	CcSEcCtD
Triamcinolone—Conjunctivitis—Doxorubicin—liver cancer	0.0014	0.00217	CcSEcCtD
Triamcinolone—Haemorrhage—Epirubicin—liver cancer	0.0014	0.00216	CcSEcCtD
Triamcinolone—Pharyngitis—Epirubicin—liver cancer	0.00139	0.00215	CcSEcCtD
Triamcinolone—Epistaxis—Doxorubicin—liver cancer	0.00136	0.0021	CcSEcCtD
Triamcinolone—Bradycardia—Doxorubicin—liver cancer	0.00132	0.00204	CcSEcCtD
Triamcinolone—Haemoglobin—Doxorubicin—liver cancer	0.0013	0.00201	CcSEcCtD
Triamcinolone—Rhinitis—Doxorubicin—liver cancer	0.0013	0.00201	CcSEcCtD
Triamcinolone—Haemorrhage—Doxorubicin—liver cancer	0.0013	0.002	CcSEcCtD
Triamcinolone—Pharyngitis—Doxorubicin—liver cancer	0.00129	0.00199	CcSEcCtD
Triamcinolone—Arrhythmia—Epirubicin—liver cancer	0.00125	0.00193	CcSEcCtD
Triamcinolone—Erythema—Epirubicin—liver cancer	0.00122	0.00188	CcSEcCtD
Triamcinolone—Dysgeusia—Epirubicin—liver cancer	0.00119	0.00184	CcSEcCtD
Triamcinolone—Back pain—Epirubicin—liver cancer	0.00118	0.00182	CcSEcCtD
Triamcinolone—Arrhythmia—Doxorubicin—liver cancer	0.00116	0.00179	CcSEcCtD
Triamcinolone—Ill-defined disorder—Epirubicin—liver cancer	0.00113	0.00175	CcSEcCtD
Triamcinolone—Erythema—Doxorubicin—liver cancer	0.00113	0.00174	CcSEcCtD
Triamcinolone—Dysgeusia—Doxorubicin—liver cancer	0.00111	0.00171	CcSEcCtD
Triamcinolone—Malaise—Epirubicin—liver cancer	0.0011	0.0017	CcSEcCtD
Triamcinolone—Vertigo—Epirubicin—liver cancer	0.0011	0.00169	CcSEcCtD
Triamcinolone—Syncope—Epirubicin—liver cancer	0.00109	0.00169	CcSEcCtD
Triamcinolone—Back pain—Doxorubicin—liver cancer	0.00109	0.00169	CcSEcCtD
Triamcinolone—Loss of consciousness—Epirubicin—liver cancer	0.00107	0.00166	CcSEcCtD
Triamcinolone—Cough—Epirubicin—liver cancer	0.00106	0.00164	CcSEcCtD
Triamcinolone—PTGS2—gall bladder—liver cancer	0.00106	0.0874	CbGeAlD
Triamcinolone—Convulsion—Epirubicin—liver cancer	0.00106	0.00163	CcSEcCtD
Triamcinolone—Hypertension—Epirubicin—liver cancer	0.00105	0.00163	CcSEcCtD
Triamcinolone—Ill-defined disorder—Doxorubicin—liver cancer	0.00105	0.00162	CcSEcCtD
Triamcinolone—Myalgia—Epirubicin—liver cancer	0.00104	0.0016	CcSEcCtD
Triamcinolone—Discomfort—Epirubicin—liver cancer	0.00103	0.00158	CcSEcCtD
Triamcinolone—Malaise—Doxorubicin—liver cancer	0.00102	0.00157	CcSEcCtD
Triamcinolone—Dry mouth—Epirubicin—liver cancer	0.00102	0.00157	CcSEcCtD
Triamcinolone—Vertigo—Doxorubicin—liver cancer	0.00101	0.00157	CcSEcCtD
Triamcinolone—Syncope—Doxorubicin—liver cancer	0.00101	0.00156	CcSEcCtD
Triamcinolone—Anaphylactic shock—Epirubicin—liver cancer	0.000995	0.00154	CcSEcCtD
Triamcinolone—Oedema—Epirubicin—liver cancer	0.000995	0.00154	CcSEcCtD
Triamcinolone—Loss of consciousness—Doxorubicin—liver cancer	0.000992	0.00153	CcSEcCtD
Triamcinolone—Infection—Epirubicin—liver cancer	0.000989	0.00153	CcSEcCtD
Triamcinolone—Cough—Doxorubicin—liver cancer	0.000985	0.00152	CcSEcCtD
Triamcinolone—Fluoxymesterone—ESR1—liver cancer	0.00098	0.324	CrCbGaD
Triamcinolone—Shock—Epirubicin—liver cancer	0.000979	0.00151	CcSEcCtD
Triamcinolone—Convulsion—Doxorubicin—liver cancer	0.000978	0.00151	CcSEcCtD
Triamcinolone—Hypertension—Doxorubicin—liver cancer	0.000974	0.0015	CcSEcCtD
Triamcinolone—Tachycardia—Epirubicin—liver cancer	0.000972	0.0015	CcSEcCtD
Triamcinolone—Hyperhidrosis—Epirubicin—liver cancer	0.000962	0.00149	CcSEcCtD
Triamcinolone—Myalgia—Doxorubicin—liver cancer	0.000961	0.00148	CcSEcCtD
Triamcinolone—Discomfort—Doxorubicin—liver cancer	0.000949	0.00147	CcSEcCtD
Triamcinolone—Clobetasol propionate—CYP1A1—liver cancer	0.000948	0.314	CrCbGaD
Triamcinolone—Dry mouth—Doxorubicin—liver cancer	0.00094	0.00145	CcSEcCtD
Triamcinolone—Oedema—Doxorubicin—liver cancer	0.000921	0.00142	CcSEcCtD
Triamcinolone—Anaphylactic shock—Doxorubicin—liver cancer	0.000921	0.00142	CcSEcCtD
Triamcinolone—Infection—Doxorubicin—liver cancer	0.000915	0.00141	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000907	0.0014	CcSEcCtD
Triamcinolone—Shock—Doxorubicin—liver cancer	0.000906	0.0014	CcSEcCtD
Triamcinolone—Insomnia—Epirubicin—liver cancer	0.0009	0.00139	CcSEcCtD
Triamcinolone—Tachycardia—Doxorubicin—liver cancer	0.000899	0.00139	CcSEcCtD
Triamcinolone—Paraesthesia—Epirubicin—liver cancer	0.000894	0.00138	CcSEcCtD
Triamcinolone—Hyperhidrosis—Doxorubicin—liver cancer	0.00089	0.00137	CcSEcCtD
Triamcinolone—Dyspnoea—Epirubicin—liver cancer	0.000888	0.00137	CcSEcCtD
Triamcinolone—Dyspepsia—Epirubicin—liver cancer	0.000876	0.00135	CcSEcCtD
Triamcinolone—Fatigue—Epirubicin—liver cancer	0.000858	0.00133	CcSEcCtD
Triamcinolone—Pain—Epirubicin—liver cancer	0.000851	0.00131	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000839	0.0013	CcSEcCtD
Triamcinolone—Insomnia—Doxorubicin—liver cancer	0.000833	0.00129	CcSEcCtD
Triamcinolone—Paraesthesia—Doxorubicin—liver cancer	0.000827	0.00128	CcSEcCtD
Triamcinolone—Dyspnoea—Doxorubicin—liver cancer	0.000821	0.00127	CcSEcCtD
Triamcinolone—Feeling abnormal—Epirubicin—liver cancer	0.00082	0.00127	CcSEcCtD
Triamcinolone—SERPINA6—liver—liver cancer	0.000818	0.0676	CbGeAlD
Triamcinolone—Dyspepsia—Doxorubicin—liver cancer	0.000811	0.00125	CcSEcCtD
Triamcinolone—Fatigue—Doxorubicin—liver cancer	0.000794	0.00123	CcSEcCtD
Triamcinolone—Urticaria—Epirubicin—liver cancer	0.000791	0.00122	CcSEcCtD
Triamcinolone—Pain—Doxorubicin—liver cancer	0.000788	0.00122	CcSEcCtD
Triamcinolone—Body temperature increased—Epirubicin—liver cancer	0.000787	0.00122	CcSEcCtD
Triamcinolone—NR3C1—embryo—liver cancer	0.000775	0.064	CbGeAlD
Triamcinolone—Feeling abnormal—Doxorubicin—liver cancer	0.000759	0.00117	CcSEcCtD
Triamcinolone—Hypersensitivity—Epirubicin—liver cancer	0.000733	0.00113	CcSEcCtD
Triamcinolone—Urticaria—Doxorubicin—liver cancer	0.000732	0.00113	CcSEcCtD
Triamcinolone—Body temperature increased—Doxorubicin—liver cancer	0.000728	0.00112	CcSEcCtD
Triamcinolone—Asthenia—Epirubicin—liver cancer	0.000714	0.0011	CcSEcCtD
Triamcinolone—Pruritus—Epirubicin—liver cancer	0.000704	0.00109	CcSEcCtD
Triamcinolone—Hypersensitivity—Doxorubicin—liver cancer	0.000679	0.00105	CcSEcCtD
Triamcinolone—PTGS2—embryo—liver cancer	0.00067	0.0554	CbGeAlD
Triamcinolone—Asthenia—Doxorubicin—liver cancer	0.000661	0.00102	CcSEcCtD
Triamcinolone—Dizziness—Epirubicin—liver cancer	0.000658	0.00102	CcSEcCtD
Triamcinolone—Pruritus—Doxorubicin—liver cancer	0.000652	0.00101	CcSEcCtD
Triamcinolone—Vomiting—Epirubicin—liver cancer	0.000633	0.000977	CcSEcCtD
Triamcinolone—Rash—Epirubicin—liver cancer	0.000628	0.000969	CcSEcCtD
Triamcinolone—Dermatitis—Epirubicin—liver cancer	0.000627	0.000968	CcSEcCtD
Triamcinolone—Headache—Epirubicin—liver cancer	0.000624	0.000963	CcSEcCtD
Triamcinolone—Dizziness—Doxorubicin—liver cancer	0.000609	0.00094	CcSEcCtD
Triamcinolone—Nausea—Epirubicin—liver cancer	0.000591	0.000913	CcSEcCtD
Triamcinolone—Vomiting—Doxorubicin—liver cancer	0.000586	0.000904	CcSEcCtD
Triamcinolone—Rash—Doxorubicin—liver cancer	0.000581	0.000897	CcSEcCtD
Triamcinolone—Dermatitis—Doxorubicin—liver cancer	0.00058	0.000896	CcSEcCtD
Triamcinolone—Headache—Doxorubicin—liver cancer	0.000577	0.000891	CcSEcCtD
Triamcinolone—Nausea—Doxorubicin—liver cancer	0.000547	0.000845	CcSEcCtD
Triamcinolone—NR3C1—AP-1 transcription factor network—TP53—liver cancer	0.000423	0.00125	CbGpPWpGaD
Triamcinolone—PTGS2—C-MYB transcription factor network—CCND1—liver cancer	0.00042	0.00125	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	0.00042	0.00125	CbGpPWpGaD
Triamcinolone—BCHE—Transmission across Chemical Synapses—BRAF—liver cancer	0.000418	0.00124	CbGpPWpGaD
Triamcinolone—CYP3A4—Biological oxidations—GSTA1—liver cancer	0.000416	0.00123	CbGpPWpGaD
Triamcinolone—CYP3A4—Biological oxidations—NAT2—liver cancer	0.000411	0.00122	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—EXOSC2—liver cancer	0.000411	0.00122	CbGpPWpGaD
Triamcinolone—PTGS2—C-MYB transcription factor network—CDKN1A—liver cancer	0.000407	0.00121	CbGpPWpGaD
Triamcinolone—CYP3A4—Metapathway biotransformation—NAT2—liver cancer	0.000406	0.0012	CbGpPWpGaD
Triamcinolone—BCHE—liver—liver cancer	0.000402	0.0332	CbGeAlD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—PCNA—liver cancer	0.00039	0.00116	CbGpPWpGaD
Triamcinolone—NR3C1—Adipogenesis—CTNNB1—liver cancer	0.000387	0.00115	CbGpPWpGaD
Triamcinolone—NR3C1—AP-1 transcription factor network—IL6—liver cancer	0.000387	0.00115	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—ATF3—liver cancer	0.000383	0.00114	CbGpPWpGaD
Triamcinolone—NR3C1—Adipogenesis—CDKN1A—liver cancer	0.000378	0.00112	CbGpPWpGaD
Triamcinolone—Prednisone—ALB—liver cancer	0.000376	0.125	CrCbGaD
Triamcinolone—NR3C1—Glucocorticoid receptor regulatory network—TP53—liver cancer	0.000373	0.0011	CbGpPWpGaD
Triamcinolone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.000363	0.00108	CbGpPWpGaD
Triamcinolone—Dexamethasone—CYP2E1—liver cancer	0.00036	0.119	CrCbGaD
Triamcinolone—NR3C1—liver—liver cancer	0.000358	0.0296	CbGeAlD
Triamcinolone—Dexamethasone—CYP1A1—liver cancer	0.000355	0.118	CrCbGaD
Triamcinolone—BCHE—Transmission across Chemical Synapses—RAF1—liver cancer	0.000349	0.00104	CbGpPWpGaD
Triamcinolone—NR3C1—SIDS Susceptibility Pathways—CASP3—liver cancer	0.000347	0.00103	CbGpPWpGaD
Triamcinolone—CYP3A4—Metapathway biotransformation—GPX3—liver cancer	0.000345	0.00102	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK14—liver cancer	0.000343	0.00102	CbGpPWpGaD
Triamcinolone—NR3C1—Glucocorticoid receptor regulatory network—IL6—liver cancer	0.000341	0.00101	CbGpPWpGaD
Triamcinolone—NR3C1—Adipogenesis—STAT3—liver cancer	0.000338	0.001	CbGpPWpGaD
Triamcinolone—NR3C1—SIDS Susceptibility Pathways—JUN—liver cancer	0.000337	0.001	CbGpPWpGaD
Triamcinolone—PTGS2—C-MYB transcription factor network—MYC—liver cancer	0.000337	0.001	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—liver cancer	0.000336	0.000997	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—CDKN1B—liver cancer	0.000336	0.000996	CbGpPWpGaD
Triamcinolone—NR3C1—SIDS Susceptibility Pathways—CTNNB1—liver cancer	0.000335	0.000993	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	0.000331	0.000981	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—UGDH—liver cancer	0.00033	0.000978	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—CASP3—liver cancer	0.000329	0.000976	CbGpPWpGaD
Triamcinolone—CYP3A4—Biological oxidations—HPGDS—liver cancer	0.000329	0.000975	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—IL2—liver cancer	0.000329	0.000975	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—NR1H4—liver cancer	0.000327	0.00097	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—NR1I3—liver cancer	0.000321	0.000953	CbGpPWpGaD
Triamcinolone—BCHE—Neuronal System—BRAF—liver cancer	0.00032	0.00095	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—CCND1—liver cancer	0.00032	0.00095	CbGpPWpGaD
Triamcinolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—liver cancer	0.000318	0.000942	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—APC—liver cancer	0.000318	0.000942	CbGpPWpGaD
Triamcinolone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—liver cancer	0.000315	0.000933	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—GGT1—liver cancer	0.000314	0.000932	CbGpPWpGaD
Triamcinolone—NR3C1—Adipogenesis—TGFB1—liver cancer	0.000313	0.000928	CbGpPWpGaD
Triamcinolone—PTGS2—C-MYB transcription factor network—KRAS—liver cancer	0.000312	0.000924	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—MMP9—liver cancer	0.000311	0.000922	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—EPT1—liver cancer	0.00031	0.00092	CbGpPWpGaD
Triamcinolone—PTGS2—liver—liver cancer	0.00031	0.0256	CbGeAlD
Triamcinolone—PTGS2—Selenium Micronutrient Network—TNF—liver cancer	0.000303	0.000898	CbGpPWpGaD
Triamcinolone—NR3C1—SIDS Susceptibility Pathways—VEGFA—liver cancer	0.000295	0.000874	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—TAT—liver cancer	0.000294	0.000872	CbGpPWpGaD
Triamcinolone—NR3C1—Adipogenesis—TNF—liver cancer	0.000292	0.000867	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—CPT1B—liver cancer	0.00029	0.000861	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—GLUL—liver cancer	0.00029	0.000861	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	0.000289	0.000858	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—NR1H4—liver cancer	0.00028	0.00083	CbGpPWpGaD
Triamcinolone—BCHE—Phospholipid metabolism—PIK3CA—liver cancer	0.00028	0.000829	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—GSTA3—liver cancer	0.000275	0.000816	CbGpPWpGaD
Triamcinolone—CYP3A4—liver—liver cancer	0.000271	0.0224	CbGeAlD
Triamcinolone—CYP3A4—Biological oxidations—CYP2E1—liver cancer	0.000268	0.000795	CbGpPWpGaD
Triamcinolone—BCHE—Neuronal System—RAF1—liver cancer	0.000267	0.000793	CbGpPWpGaD
Triamcinolone—PTGS2—C-MYB transcription factor network—HRAS—liver cancer	0.000265	0.000785	CbGpPWpGaD
Triamcinolone—CYP3A4—Metapathway biotransformation—CYP2E1—liver cancer	0.000264	0.000784	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—MYC—liver cancer	0.000257	0.000762	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—TGFB1—liver cancer	0.000256	0.00076	CbGpPWpGaD
Triamcinolone—NR3C1—SIDS Susceptibility Pathways—TNF—liver cancer	0.000253	0.000749	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—GSTA4—liver cancer	0.000252	0.000747	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—RAF1—liver cancer	0.000249	0.000739	CbGpPWpGaD
Triamcinolone—CYP3A4—Biological oxidations—GGT1—liver cancer	0.000246	0.00073	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	0.000246	0.00073	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—GSTA2—liver cancer	0.000245	0.000728	CbGpPWpGaD
Triamcinolone—PTGS2—Selenium Micronutrient Network—IL6—liver cancer	0.000244	0.000724	CbGpPWpGaD
Triamcinolone—NR3C1—Generic Transcription Pathway—PPARA—liver cancer	0.000243	0.000721	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—TNF—liver cancer	0.000239	0.00071	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—LTF—liver cancer	0.000239	0.000708	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—IGF2—liver cancer	0.000237	0.000704	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—GSTA1—liver cancer	0.000237	0.000702	CbGpPWpGaD
Triamcinolone—NR3C1—Adipogenesis—IL6—liver cancer	0.000236	0.000699	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—NAT2—liver cancer	0.000234	0.000694	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—liver cancer	0.000228	0.000677	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—PPARA—liver cancer	0.000225	0.000667	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—ALDOB—liver cancer	0.000224	0.000665	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—liver cancer	0.000224	0.000664	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—HNF4A—liver cancer	0.000223	0.000661	CbGpPWpGaD
Triamcinolone—CYP3A4—Biological oxidations—GSTP1—liver cancer	0.000221	0.000656	CbGpPWpGaD
Triamcinolone—NR3C1—Generic Transcription Pathway—ESR1—liver cancer	0.00022	0.000653	CbGpPWpGaD
Triamcinolone—CYP3A4—Metapathway biotransformation—GSTP1—liver cancer	0.000218	0.000647	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—liver cancer	0.000218	0.000646	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—liver cancer	0.000217	0.000645	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—GGT1—liver cancer	0.000216	0.000642	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—liver cancer	0.000216	0.00064	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—CRABP1—liver cancer	0.000214	0.000635	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—TP53—liver cancer	0.000211	0.000626	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—liver cancer	0.000211	0.000625	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—liver cancer	0.000206	0.00061	CbGpPWpGaD
Triamcinolone—NR3C1—SIDS Susceptibility Pathways—IL6—liver cancer	0.000204	0.000605	CbGpPWpGaD
Triamcinolone—CYP3A4—Biological oxidations—GSTM1—liver cancer	0.000203	0.000603	CbGpPWpGaD
Triamcinolone—NR3C1—Generic Transcription Pathway—PPARG—liver cancer	0.000201	0.000596	CbGpPWpGaD
Triamcinolone—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	0.0002	0.000594	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—CPT1B—liver cancer	0.0002	0.000593	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—GLUL—liver cancer	0.0002	0.000593	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—PSMA4—liver cancer	0.000195	0.000578	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—PSMD10—liver cancer	0.000195	0.000578	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—IL6—liver cancer	0.000193	0.000573	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	0.000193	0.000572	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—NR1H4—liver cancer	0.000193	0.000571	CbGpPWpGaD
Triamcinolone—CYP3A4—Biological oxidations—CYP1A1—liver cancer	0.000193	0.000571	CbGpPWpGaD
Triamcinolone—BCHE—Transmission across Chemical Synapses—HRAS—liver cancer	0.000192	0.00057	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—liver cancer	0.00019	0.000563	CbGpPWpGaD
Triamcinolone—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	0.00019	0.000563	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—GSTA3—liver cancer	0.000189	0.000562	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—HPGDS—liver cancer	0.000187	0.000555	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—PPARG—liver cancer	0.000186	0.000552	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—ALDOB—liver cancer	0.000184	0.000547	CbGpPWpGaD
Triamcinolone—NR3C1—Generic Transcription Pathway—SERPINE1—liver cancer	0.000181	0.000537	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	0.000175	0.000518	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	0.000174	0.000517	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—F2—liver cancer	0.000174	0.000516	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—GSTA4—liver cancer	0.000173	0.000514	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	0.000169	0.000502	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	0.000169	0.000502	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—GSTA2—liver cancer	0.000169	0.000501	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—ALB—liver cancer	0.000167	0.000496	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—PSMD10—liver cancer	0.000167	0.000495	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—PSMA4—liver cancer	0.000167	0.000495	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—GSTA1—liver cancer	0.000163	0.000483	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	0.000163	0.000483	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—GOT2—liver cancer	0.000162	0.000481	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	0.000162	0.000479	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—NAT2—liver cancer	0.000161	0.000478	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—PPARA—liver cancer	0.000155	0.000459	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—ALDOB—liver cancer	0.000154	0.000458	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—CYP2E1—liver cancer	0.000153	0.000452	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	0.000148	0.00044	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	0.000148	0.000438	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—MMP2—liver cancer	0.000148	0.000438	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—CRABP1—liver cancer	0.000147	0.000437	CbGpPWpGaD
Triamcinolone—BCHE—Neuronal System—HRAS—liver cancer	0.000147	0.000437	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—ADAM17—liver cancer	0.000146	0.000432	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—UGDH—liver cancer	0.000144	0.000427	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	0.000144	0.000426	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—CYCS—liver cancer	0.000143	0.000423	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—GOT1—liver cancer	0.00014	0.000415	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—GGT1—liver cancer	0.00014	0.000415	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—PSMD10—liver cancer	0.000137	0.000406	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—PSMA4—liver cancer	0.000137	0.000406	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—EPT1—liver cancer	0.000135	0.000402	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—GOT2—liver cancer	0.000133	0.000395	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	0.000133	0.000393	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—H2AFX—liver cancer	0.000132	0.00039	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—HPGDS—liver cancer	0.000129	0.000382	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—TAT—liver cancer	0.000128	0.000381	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	0.000128	0.00038	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—GSTP1—liver cancer	0.000126	0.000373	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—HMOX1—liver cancer	0.000124	0.000368	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	0.000121	0.000359	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—PPARA—liver cancer	0.000117	0.000347	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	0.000117	0.000346	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—GSTM1—liver cancer	0.000116	0.000343	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—ALB—liver cancer	0.000115	0.000341	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—GOT1—liver cancer	0.000115	0.000341	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—PSMD10—liver cancer	0.000115	0.00034	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—PSMA4—liver cancer	0.000115	0.00034	CbGpPWpGaD
Triamcinolone—NR3C1—Generic Transcription Pathway—MYC—liver cancer	0.000115	0.00034	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—CTNNB1—liver cancer	0.000113	0.000335	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—GOT2—liver cancer	0.000112	0.000331	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—CYP1A1—liver cancer	0.00011	0.000325	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—MAPK14—liver cancer	0.000108	0.000321	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—PRKCE—liver cancer	0.000106	0.000315	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—ESR1—liver cancer	0.000106	0.000314	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—CYP2E1—liver cancer	0.000105	0.000311	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—MTHFR—liver cancer	0.000102	0.000303	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	0.000102	0.000301	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—PPARA—liver cancer	0.0001	0.000297	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—CYCS—liver cancer	9.82e-05	0.000291	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—PPARG—liver cancer	9.68e-05	0.000287	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—GOT1—liver cancer	9.64e-05	0.000286	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—GGT1—liver cancer	9.64e-05	0.000286	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—H2AFX—liver cancer	9.26e-05	0.000275	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	9e-05	0.000267	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—CPT1B—liver cancer	8.73e-05	0.000259	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—GLUL—liver cancer	8.73e-05	0.000259	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—SERPINE1—liver cancer	8.72e-05	0.000258	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—GSTP1—liver cancer	8.66e-05	0.000257	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—PIK3CG—liver cancer	8.58e-05	0.000255	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—HMOX1—liver cancer	8.54e-05	0.000253	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—NR1H4—liver cancer	8.42e-05	0.00025	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—MTHFR—liver cancer	8.4e-05	0.000249	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—TERT—liver cancer	8.37e-05	0.000248	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—PPARG—liver cancer	8.28e-05	0.000246	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—GSTA3—liver cancer	8.27e-05	0.000245	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—GSTM1—liver cancer	7.96e-05	0.000236	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—GSTA4—liver cancer	7.57e-05	0.000224	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—PIK3CD—liver cancer	7.55e-05	0.000224	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—CYP1A1—liver cancer	7.54e-05	0.000224	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—ALB—liver cancer	7.45e-05	0.000221	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—GSTA2—liver cancer	7.37e-05	0.000219	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—GSTA1—liver cancer	7.11e-05	0.000211	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—APC—liver cancer	7.05e-05	0.000209	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—NAT2—liver cancer	7.04e-05	0.000209	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—MTHFR—liver cancer	7.03e-05	0.000209	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—PPARA—liver cancer	6.9e-05	0.000205	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—ALDOB—liver cancer	6.74e-05	0.0002	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—BRAF—liver cancer	6.63e-05	0.000197	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—PIK3CB—liver cancer	6.58e-05	0.000195	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—CRABP1—liver cancer	6.43e-05	0.000191	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—PIK3CD—liver cancer	6.2e-05	0.000184	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	6.2e-05	0.000184	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—SERPINE1—liver cancer	6.13e-05	0.000182	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—PIK3CG—liver cancer	5.91e-05	0.000175	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—PPARG—liver cancer	5.7e-05	0.000169	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—HPGDS—liver cancer	5.62e-05	0.000167	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—RAF1—liver cancer	5.54e-05	0.000164	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—MYC—liver cancer	5.52e-05	0.000164	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—PIK3CB—liver cancer	5.41e-05	0.00016	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—MTOR—liver cancer	5.41e-05	0.00016	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—PIK3CD—liver cancer	5.19e-05	0.000154	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—ALB—liver cancer	5.13e-05	0.000152	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—CDKN1B—liver cancer	5.07e-05	0.00015	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PSMD10—liver cancer	5.01e-05	0.000149	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PSMA4—liver cancer	5.01e-05	0.000149	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—GOT2—liver cancer	4.88e-05	0.000145	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—CTNNB1—liver cancer	4.79e-05	0.000142	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—CDKN1A—liver cancer	4.68e-05	0.000139	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—CYP2E1—liver cancer	4.58e-05	0.000136	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—PIK3CB—liver cancer	4.53e-05	0.000134	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—CYCS—liver cancer	4.29e-05	0.000127	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—GOT1—liver cancer	4.21e-05	0.000125	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—GGT1—liver cancer	4.21e-05	0.000125	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—STAT3—liver cancer	4.18e-05	0.000124	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—PIK3CA—liver cancer	4.01e-05	0.000119	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—MYC—liver cancer	3.88e-05	0.000115	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—TGFB1—liver cancer	3.87e-05	0.000115	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—AKT1—liver cancer	3.83e-05	0.000113	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—GSTP1—liver cancer	3.78e-05	0.000112	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—HMOX1—liver cancer	3.73e-05	0.000111	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—KRAS—liver cancer	3.59e-05	0.000106	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—GSTM1—liver cancer	3.47e-05	0.000103	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—PIK3CA—liver cancer	3.29e-05	9.77e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—CYP1A1—liver cancer	3.29e-05	9.77e-05	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—AKT1—liver cancer	3.28e-05	9.71e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—MTHFR—liver cancer	3.07e-05	9.11e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—HRAS—liver cancer	3.05e-05	9.04e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PPARA—liver cancer	3.01e-05	8.93e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—IL6—liver cancer	2.92e-05	8.65e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—PIK3CA—liver cancer	2.76e-05	8.18e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—AKT1—liver cancer	2.69e-05	7.98e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PIK3CG—liver cancer	2.58e-05	7.65e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PPARG—liver cancer	2.49e-05	7.38e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PIK3CD—liver cancer	2.27e-05	6.73e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—AKT1—liver cancer	2.25e-05	6.69e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—ALB—liver cancer	2.24e-05	6.64e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PIK3CB—liver cancer	1.98e-05	5.86e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PIK3CA—liver cancer	1.21e-05	3.57e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—AKT1—liver cancer	9.85e-06	2.92e-05	CbGpPWpGaD
